Cartesian Therapeutics, Inc. (RNAC) SEC Filings — 2024

Filings

• Cartesian Therapeutics Files 8-K — 8-K · Dec 3, 2024
• Springer Amends Cartesian Therapeutics Stake — SC 13D/A · Nov 18, 2024
• Cartesian Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
• Cartesian Therapeutics Ownership Update — SC 13D/A · Oct 15, 2024
• Springer Amends Stake in Cartesian Therapeutics — SC 13D/A · Oct 4, 2024
• Springer Amends 13D Filing for Cartesian Therapeutics — SC 13D/A · Sep 27, 2024
• Cartesian Therapeutics to be Acquired by 03 Life Sciences — 8-K · Sep 26, 2024
• Cartesian Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Sep 23, 2024
• Cartesian Therapeutics Files S-1/A Amendment — S-1/A · Sep 20, 2024
• Cartesian Therapeutics Files S-1/A Amendment — S-1/A · Sep 9, 2024
• Cartesian Therapeutics Files Proxy Statement for Annual Meeting — DEF 14A · Aug 16, 2024
• Cartesian Therapeutics, Inc. SC 13G Filing — SC 13G · Aug 12, 2024
• Cartesian Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
• Cartesian Therapeutics Files S-1 for Public Offering — S-1 · Aug 2, 2024
• Cartesian Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jul 12, 2024
• Springer Amends Cartesian Therapeutics Stake Filing — SC 13D/A · Jul 5, 2024
• Cartesian Therapeutics Files 8-K with Material Agreements & Officer Changes — 8-K · Jul 2, 2024
• Cartesian Therapeutics Announces Board Changes and Shareholder Votes — 8-K · Jun 17, 2024
• Cartesian Therapeutics Files 8-K — 8-K · May 22, 2024
• Cartesian Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · May 10, 2024
• Cartesian Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
• Cartesian Therapeutics, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 26, 2024
• Cartesian Therapeutics Files 8-K — 8-K · Apr 22, 2024
• Springer Amends 13D Filing for Cartesian Therapeutics — SC 13D/A · Apr 12, 2024
• Singer Amends Cartesian Therapeutics Stake Filing — SC 13D/A · Apr 10, 2024
• Cartesian Therapeutics Files 8-K: Regulation FD Disclosure — 8-K · Apr 9, 2024
• Cartesian Therapeutics Appoints New Chief Medical Officer — 8-K · Apr 1, 2024
• Springer Amends Stake in Cartesian Therapeutics — SC 13D/A · Mar 28, 2024
• Cartesian Therapeutics Completes Merger with 03 Life Sciences — 8-K · Mar 28, 2024
• Cartesian Therapeutics Terminates Material Agreement — 8-K · Mar 14, 2024
• Cartesian Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Mar 11, 2024
• Cartesian Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
• Cartesian Therapeutics Announces Executive and Board Changes — 8-K · Mar 5, 2024
• Cartesian Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Cartesian Therapeutics, Inc. Announces Special Meeting of Stockholders — DEF 14A · Feb 14, 2024
• Artal Group Affiliates Maintain Significant Stake in Cartesian Therapeutics — SC 13G/A · Feb 9, 2024
• FMR LLC Discloses 8.186% Stake in Cartesian Therapeutics — SC 13G · Feb 9, 2024
• Cartesian Therapeutics Amends 8-K, Updates HQ Address — 8-K/A · Jan 23, 2024
• Cartesian Therapeutics (RNAC) Faces Nasdaq Delisting for Low Bid Price — 8-K · Jan 19, 2024
• Cartesian Therapeutics Files 8-K for Corporate Communications — 8-K · Jan 8, 2024